share_log

CORRECTION: On January 19, 2023, Biora Therapeutics Received A Letter From Nasdaq Notifying The Co. That The Co.'s Previously Announced Bid Price Deficiency Had Been Cured And The Co. Was In Compliance With All Applicable Continued Listing Standards

Benzinga Real-time News ·  Jan 23, 2023 08:57
CORRECTION: On January 19, 2023, Biora Therapeutics Received A Letter From Nasdaq Notifying The Co. That The Co.'s Previously Announced Bid Price Deficiency Had Been Cured And The Co. Was In Compliance With All Applicable Continued Listing Standards
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment